Success Metrics

Clinical Success Rate
97.4%

Based on 37 completed trials

Completion Rate
97%(37/38)
Active Trials
3(5%)
Results Posted
5%(2 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
1
2%
Ph phase_4
3
5%
Ph not_applicable
34
52%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution38 total trials
Phase 2Efficacy & side effects
1(2.6%)
Phase 4Post-market surveillance
3(7.9%)
N/ANon-phased studies
34(89.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.1%

37 of 42 finished

Non-Completion Rate

11.9%

5 ended early

Currently Active

3

trials recruiting

Total Trials

66

all time

Status Distribution
Active(5)
Completed(37)
Terminated(5)
Other(19)

Detailed Status

Completed37
unknown19
Withdrawn4
Active, not recruiting3
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
66
Active
3
Success Rate
97.4%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (2.6%)
Phase 43 (7.9%)
N/A34 (89.5%)

Trials by Status

withdrawn46%
completed3756%
not_yet_recruiting23%
active_not_recruiting35%
unknown1929%
terminated12%

Recent Activity

Clinical Trials (66)

Showing 20 of 66 trialsScroll for more
NCT07564986

Relationship Between Serum Resistin Levels and Reduction in Visceral Fat in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

Completed
NCT07564973

The Effect of Adiponectin-Leptin Ratio on Weight Loss in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

Completed
NCT07461610

Stool Analysis After Sleeve Gastrectomy vs Gastric Bypass

Not Yet Recruiting
NCT06254183Phase 4

Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)

Completed
NCT07413237

Outcomes of Single Anastomosis Sleeve Jejunal Bypass (SAS-J) VS Sleeve Gastrectomy

Completed
NCT07325916

Relationship Between Serum Apolipoprotein Levels and Weight Loss in Patients Undergoing Sleeve Gastrectomy for Morbid Obesity

Active Not Recruiting
NCT01513005Not Applicable

Feasibility of Laparoscopic Sleeve Gastrectomy in Day Case Surgery

Completed
NCT01539967Not Applicable

Impact of the Residual Gastric Volume in Laparoscopic Sleeve Gastrectomy's Failure

Completed
NCT06835933

Postoperative Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy Based on the Presence of Preoperative Symptoms

Active Not Recruiting
NCT06859320Not Applicable

Outcomes Of Laparoscopic Sleeve Gastrectomy In Patients With Hypothyroidism And Depression

Active Not Recruiting
NCT02733770Not Applicable

Chances in Portal System Flow After Two Bariatric Procedures

Withdrawn
NCT06820047

Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study

Completed
NCT06767787Not Applicable

Morbid Obesity and Severe Knee Osteoarthritis - Which Should Be Treated First?

Not Yet Recruiting
NCT06284356

Pan Immune Inflammation Value for Perioperative Complications of Laparoscopic Sleeve Gastrectomy

Completed
NCT06170060Not Applicable

Treatment of Reflux With Sleeve Gastrectomy

Unknown
NCT04237857

Long Term Incidence and Effect of de Novo GERD After Laparoscopic Sleeve Gastrectomy in Chinese Population

Unknown
NCT05892224

Study on Brain Function of Obesity Classification

Unknown
NCT00965302Not Applicable

Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients

Terminated
NCT05826210

Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life After Laparoscopic Sleeve Gastrectomy

Completed
NCT04508634Phase 4

Treating Obese PCOS Patients With LSG vs. Met

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
66